News


24 Apr 2018

BLUEJAY DIAGNOSTICS, INC. ANNOUNCES PARTICIPATION AT URGENT CARE CONFERENCE

Bluejay Diagnostics is pleased to announce that we will be exhibiting at the Spring 2018 Urgent Care Association of America Conference. Acton, MA – April 23, 2018 – Bluejay Diagnostics, Inc. (Bluejay) is pleased to announce that we will be exhibiting at the Spring 2018 Urgent Care Association of America (“UCAOA”) Conference.  The event takes place May 6 – 9, 2018 at the Paris Hotel...

Read More


22 May 2017

Bluejay Diagnostics’ Board of Directors Announces Appointment of Douglas C. Wurth as Chairman

Acton, MA – May 22, 2017 – Bluejay Diagnostics, Inc. (Bluejay) today announced that its board of directors unanimously named Douglas C. Wurth as the Company’s chairman, effective immediately. Mr. Wurth recently retired from J.P. Morgan Chase after a successful 19-year career with the Firm, where he was the Chief Executive Officer of Alternative Investments for J.P. Morgan Asset Management. In this role, he led...

Read More


27 Feb 2017

Bluejay Diagnostics, Inc. Announces Clinical Research Collaboration to Development of Care Test for Allergic Conjunctivitis

Collaboration focused on developing non-invasive diagnostic test to identify total IgE in human tears. Acton, MA – February 27, 2017 – Bluejay Diagnostics, Inc. (Bluejay) today announced a collaborative clinical research agreement with Hitachi Chemical Co., Ltd. (Hitachi Chemical) to develop a non-invasive, point-of-care test that measures total IgE in human tears. The technology could be used to aid in the diagnosis of Allergic Conjunctivitis,...

Read More